Treatment of pediatric refractory or relapsed Epstein–Barr virus‐associated hemophagocytic syndrome with PD‐1 inhibitors
Year: 2024
Type: article
Study design: Case Report
Source: Pediatric Blood & Cancer
DOI: 10.1002/pbc.31340
Institutions: Sun Yat-sen University, Sun Yat-sen Memorial Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G2408862021
OpenAlex ID: W4402950201
